BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36150989)

  • 1. Bilateral retinal vein occlusion after two doses of SARS-CoV-2 adenovirus vector-based vaccine.
    Fernández-Vigo JI; Perálvarez Conde C; Burgos-Blasco B; Fernández-Vigo JA
    J Fr Ophtalmol; 2022 Nov; 45(9):e397-e399. PubMed ID: 36150989
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination.
    Panigrahi PK
    Indian J Ophthalmol; 2022 May; 70(5):1862. PubMed ID: 35502108
    [No Abstract]   [Full Text] [Related]  

  • 3. Retinal artery/vein occlusion complicating SARS-CoV-2 vaccinations.
    Finsterer J
    J Stroke Cerebrovasc Dis; 2022 Sep; 31(9):106617. PubMed ID: 35786536
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral retinal vein occlusion after COVID-19 vaccination: Correspondence.
    Unpuntipantip RM; Wiwanitkit V
    J Fr Ophtalmol; 2023 Feb; 46(2):e53. PubMed ID: 36628694
    [No Abstract]   [Full Text] [Related]  

  • 5. Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review.
    Yeo S; Kim H; Lee J; Yi J; Chung YR
    Graefes Arch Clin Exp Ophthalmol; 2023 Jul; 261(7):1793-1808. PubMed ID: 36598554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central retinal vein occlusion post-COVID-19 vaccination.
    Sonawane NJ; Yadav D; Kota AR; Singh HV
    Indian J Ophthalmol; 2022 Jan; 70(1):308-309. PubMed ID: 34937265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Red Flags for Risk of Retinal Vascular Occlusion After mRNA COVID-19 Vaccination.
    Jampol LM; Maguire MG
    JAMA Ophthalmol; 2023 May; 141(5):447-448. PubMed ID: 37052902
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Doerfler W
    Virus Res; 2021 Sep; 302():198466. PubMed ID: 34087261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
    Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
    [No Abstract]   [Full Text] [Related]  

  • 10. Morning Vaccination Compared with Afternoon/Evening Vaccination on Humoral Response to SARS-CoV-2 Adenovirus Vector-Based Vaccine in Hemodialysis Patients.
    Lin TY; Hung SC
    Clin J Am Soc Nephrol; 2023 Aug; 18(8):1077-1079. PubMed ID: 37220168
    [No Abstract]   [Full Text] [Related]  

  • 11. Retinal vein occlusion in the general population after COVID-19 vaccination and infection.
    Napal B; García-Palacios JD; González-Mesones B; Napal JJ; Hernández JL
    Med Clin (Barc); 2023 Sep; 161(6):231-237. PubMed ID: 37263839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report.
    Endo B; Bahamon S; Martínez-Pulgarín DF
    Indian J Ophthalmol; 2021 Oct; 69(10):2865-2866. PubMed ID: 34571653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal venous occlusion following COVID-19 vaccination: Report of a case after third dose and review of the literature.
    Dutta Majumder P; Prakash VJ
    Indian J Ophthalmol; 2022 Jun; 70(6):2191-2194. PubMed ID: 35648014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
    Madhavan M; Ritchie AJ; Aboagye J; Jenkin D; Provstgaad-Morys S; Tarbet I; Woods D; Davies S; Baker M; Platt A; Flaxman A; Smith H; Belij-Rammerstorfer S; Wilkins D; Kelly EJ; Villafana T; Green JA; Poulton I; Lambe T; Hill AVS; Ewer KJ; Douglas AD
    EBioMedicine; 2022 Nov; 85():104298. PubMed ID: 36229342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on: Retinal venous occlusion in a child following Corbevax COVID-19 vaccination.
    Panigrahi PK; Mohanty L
    Indian J Ophthalmol; 2023 Jun; 71(6):2619. PubMed ID: 37322711
    [No Abstract]   [Full Text] [Related]  

  • 16. Branch retinal vein occlusion after COVID-19.
    Nourinia R; Ghassempour M; Ahmadieh H; Abtahi SH
    J Fr Ophtalmol; 2021 Oct; 44(8):e441-e443. PubMed ID: 34325925
    [No Abstract]   [Full Text] [Related]  

  • 17. Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine.
    Bialasiewicz AA; Farah-Diab MS; Mebarki HT
    Int Ophthalmol; 2021 Dec; 41(12):3889-3892. PubMed ID: 34426861
    [No Abstract]   [Full Text] [Related]  

  • 18. Retinal vascular occlusion and SARS-CoV-2 vaccination.
    Vujosevic S; Limoli C; Romano S; Vitale L; Villani E; Nucci P
    Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3455-3464. PubMed ID: 35612613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal venous occlusion in a child following Corbevax COVID-19 vaccination.
    Nangia P; Prakash VJ; Dutta Majumder P
    Indian J Ophthalmol; 2022 Oct; 70(10):3713-3715. PubMed ID: 36190080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral retinal vein occlusion and diabetic retinopathy after COVID-19.
    Rego Lorca D; Rouco Fernandez A; Jimenez Santos M; Saenz-Frances F; Burgos-Blasco B; Donate Lopez J
    Acta Ophthalmol; 2021 Nov; 99(7):e1246-e1248. PubMed ID: 33354904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.